Axsome Therapeutics, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Axsome Therapeutics, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Axsome Therapeutics, Inc. stocks after a simple registration process. </div>

Q: How to buy Axsome Therapeutics, Inc. shares in India?

<div> To buy Axsome Therapeutics, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Axsome Therapeutics, Inc. and you are done!</div> </div>

Q: What is the share price of Axsome Therapeutics, Inc.?

<div>The share price of Axsome Therapeutics, Inc. is USD 91.71 as on 18 Dec.</div>

Q: What is the Market Capitalization of Axsome Therapeutics, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Axsome Therapeutics, Inc. is USD 4.44B as on 18 Dec.</div>

Q: What is the PE ratio of Axsome Therapeutics, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Axsome Therapeutics, Inc. is N/A as on 18 Dec. </div>

Q: Is Axsome Therapeutics, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Axsome Therapeutics, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Axsome Therapeutics, Inc. operate?

<div> Axsome Therapeutics, Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$91.71

-1.80

(18 Dec)

Loading Chart

Previous close

$91.71

Open

$91.71

Today’s high

$94.64

Today’s low

$91.53

52W low

$64.11

52W high

$105

25.21%

0.47%

EPS (TTM)

-6.58

Shares O/S

48.46M

Market cap

4.44B

Insights

AXSM has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.

AXSM price is below its 200 day moving average

In beta. Send feedback here.

Compare with other stock

About Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in developing and delivering therapies for central nervous system (CNS), conditions that have limited treatment options. The Company's two commercial products and development programs are Auvelity and Sunosi. Auvelity (dextromethorphan-bupropion) is an oral, N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder (MDD).

Sunosi (solriamfetol) is an oral medication indicated for the treatment of excessive daytime sleepiness (EDS), in patients with narcolepsy or obstructive sleep apnea. AXS-05 is an oral, investigational NMDA receptor antagonist with multimodal activity under development for the treatment of Alzheimer's disease agitation (AD agitation) and smoking cessation. AXS-07 is an oral, rapidly absorbed, multi-mechanistic, investigational medicine under development for the acute treatment of migraine. .

FAQs

Can I buy Axsome Therapeutics, Inc. shares in India?

How to buy Axsome Therapeutics, Inc. shares in India?

What is the share price of Axsome Therapeutics, Inc.?

What is the Market Capitalization of Axsome Therapeutics, Inc.?

What is the PE ratio of Axsome Therapeutics, Inc.?

Is Axsome Therapeutics, Inc. a good stock to buy?

In which sector / industry does Axsome Therapeutics, Inc. operate?